Under Armour (UAA) is a well-covered stock tracked by 32 Wall Street analysts. Competitors Nike (NKE), Columbia Sportswear (COLM), and Lululemon Athletica (LULU) have better ratings of 2.2, 2.2, and 2.3, respectively. Of the 32 analysts covering UAA, 50% are recommending a “hold” for the stock.
Canada's main stock index edged higher on Friday as energy and interest rate sensitive shares notched gains, with the index outperforming Wall Street and clawing back some of its weekly decline. The Toronto Stock Exchange's S&P/TSX composite index ended up 98.93 points, or 0.5%, at 21,807.37, its third straight day of gains. The Nasdaq and the S&P 500, two major U.S. benchmark indexes, fell after mixed corporate earnings and amid growing pessimism that the Federal Reserve would cut interest rates soon.
The NYPD identified the man as Maxwell Azzarello, 37, who is now in critical condition in Cornell burns unit. He has a long history of posting conspiracy theories and railing against the rich and powerful
EDISON, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic liver diseases, today announced that it has begun wind-down activities in its ASCEND-NASH Trial, while continuing to explore strategic alternatives, as previously announced in December 2023. ASCEND-NASH is a Phase 2b, randomized, m
VANCOUVER, B.C., April 19, 2024 (GLOBE NEWSWIRE) -- WEST MINING CORP. (“WEST” OR THE “COMPANY”) (CSE: WEST) (OTC: WESMF) (FRA: 1HL) is pleased to announce plans to complete an extensive core resampling program on its 100% owned Kena and Daylight Properties, collectively known as the Company’s flagship “Kena” Gold and Copper Project, located in the Nelson Mining District of southeastern British Columbia. In 2021, Moose Mountain Technical Services (“MMTS”) produced a resource estimate for the Kena
CHASKA, Minn., April 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that, on April 15, 2024, the Company received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the fiscal quarter ended February 25, 2024 (the “Q3 Form 10-Q”) and its continued delay in filing its Quarter
DUBLIN, Ohio, April 19, 2024--reAlpha Tech Corp. ("reAlpha," the "Company," "us," "we" or "our") (Nasdaq: AIRE), a real estate technology company focused on developing, utilizing and commercializing real estate-focused artificial intelligence ("AI") technologies, today reports financial results for the first quarter ended March 31, 2024.
DULUTH, Ga., April 19, 2024--Asbury Automotive Announces Chief Legal Officer George Villasana to Retire
ST. LOUIS, April 19, 2024--EyeCare Partners LLC ("EyeCare Partners", or the "Company"), the nation’s leading provider of clinically integrated eye care, announced today it has closed a private debt exchange with holders of a majority of its existing term loans. In addition, the Company plans to launch a public debt exchange offer to remaining lenders, which is expected to further benefit the Company through incremental debt discount capture and debt service flexibility.
TAMPA, Fla., April 19, 2024--Odyssey Marine Exploration, Inc. (NASDAQ: OMEX), a global subsea mineral exploration and validation company, reported that on April 17, 2024, Odyssey received a notice from Nasdaq Regulation that Odyssey is not in compliance with Nasdaq Rule 5250(c)(1) because it had not yet filed its Form 10-K for the period ended December 31, 2023 (the "Form 10-K") with the Securities and Exchange Commission (SEC). Odyssey plans to regain compliance with Nasdaq Rule 5250(c)(1) by f
NEW YORK, April 19, 2024--The Central and Eastern Europe Fund, Inc. (NYSE: CEE) and The New Germany Fund, Inc. (NYSE: GF) (each, a "Fund," and, collectively, the "Funds") announced today that the Annual Meeting of Stockholders for each Fund will be held at 10:00 a.m., Eastern time on June 27, 2024 at the offices of DWS Investment Management Americas, Inc., 875 Third Avenue, New York, New York 10022. Holders of shares of common stock of record of the Funds at the close of business on May 2, 2024
SAN FRANCISCO, April 19, 2024--Stem, Inc. (NYSE: STEM), a global leader in artificial intelligence (AI)-driven clean energy software and services, today announced the appointment of Gerard Cunningham to the Company’s Board of Directors (the "Board"), effective April 19, 2024.
Hong Kong, April 19, 2024 (GLOBE NEWSWIRE) -- Junee Limited (the “Company” or “Junee”), a provider of interior design, fit-out and maintenance services in Hong Kong, today announced the closing of its initial public offering (the “Offering”) of 2,000,000 ordinary shares at a price of $4.00 per share. The ordinary shares began trading on the Nasdaq Capital Market on April 17, 2024 under the ticker symbol “JUNE”. The Company received aggregate gross proceeds of $8 million from the Offering, before
SHOUGUANG, China, April 19, 2024 (GLOBE NEWSWIRE) -- Gulf Resources, Inc. (NASDAQ: GURE) (“Gulf Resources” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in China, today announced that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the Company’s failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 202
NEW YORK, April 19, 2024--The European Equity Fund, Inc. (NYSE: EEA) (the "Fund") announced today that the Annual Meeting of Stockholders for the Fund will be held at 10:30 a.m., Eastern time on June 27, 2024 at the offices of DWS Investment Management Americas, Inc., 875 Third Avenue, New York, New York 10022. Holders of shares of common stock of record of the Fund at the close of business on May 2, 2024 are entitled to vote at the meeting and any postponements or adjournments thereof. At the m
NOVATO, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare diseases, today reported the grant of 44,965 restricted stock units of the company’s common stock to 14 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Empl
Panel has obtained sworn written statement from female witness to party in Florida. Mr Gaetz has denied any wrongdoing
Nvidia and other AI stocks fell Friday after Super Micro Computer announced its next earnings date without giving preliminary results.
Shares of Schlumberger Limited (SLB) are dipping slightly on Friday as the oil drilling operator posted its first-quarter earnings, beating Wall Street revenue expectations for the quarter but disappointing on its failure to truly capitalize on the recent jump in oil prices. Yahoo Finance Anchors Julie Hyman and Madison Mills break down the latest development for the company and what it could mean for the stock moving forward. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Nicholas Jacobino
CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced its intention to voluntarily delist from the Nasdaq Global Market (“Nasdaq”) and to deregister its Class A common stock under Section 12(b) and Section 12(g) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and suspend its reporting obligations under Sectio
COLUMBUS, Ohio, April 19, 2024 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers (mBC) harboring ESR1 mutations, today announced it will host a virtual KOL fireside chat on Monday, April 22, 2024 from noon to 1 p.m. ET, featuring Senthil Damodaran, M.D., Ph.D. (MD Anderson Cancer Center) and Seth Wander, M.D., Ph.D. (Harvard Medical School, Massachusetts General Hospital
Yahoo Finance